Németh G - Search Results

1

Detection of hydrogen peroxide by lactoperoxidase-mediated dityrosine formation.

Donkó A, Orient A, Szabó PT, Németh G, Vántus T, Kéri G, Orfi L, Hunyady L, Buday L, Geiszt M. Donkó A, et al. Among authors: nemeth g. Free Radic Res. 2009 May;43(5):440-5. doi: 10.1080/10715760902859069. Free Radic Res. 2009. PMID: 19340621

2

A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.

Székely R, Wáczek F, Szabadkai I, Németh G, Hegymegi-Barakonyi B, Eros D, Szokol B, Pató J, Hafenbradl D, Satchell J, Saint-Joanis B, Cole ST, Orfi L, Klebl BM, Kéri G. Székely R, et al. Among authors: nemeth g. Immunol Lett. 2008 Mar 15;116(2):225-31. doi: 10.1016/j.imlet.2007.12.005. Epub 2008 Jan 8. Immunol Lett. 2008. PMID: 18258308

3

Signalling inhibitors against Mycobacterium tuberculosis--early days of a new therapeutic concept in tuberculosis.

Hegymegi-Barakonyi B, Székely R, Varga Z, Kiss R, Borbély G, Németh G, Bánhegyi P, Pató J, Greff Z, Horváth Z, Mészáros G, Marosfalvi J, Erōs D, Szántai-Kis C, Breza N, Garavaglia S, Perozzi S, Rizzi M, Hafenbradl D, Ko M, Av-Gay Y, Klebl BM, Orfi L, Kéri G. Hegymegi-Barakonyi B, et al. Among authors: nemeth g. Curr Med Chem. 2008;15(26):2760-70. doi: 10.2174/092986708786242886. Curr Med Chem. 2008. PMID: 18991635

4

Novel, selective CDK9 inhibitors for the treatment of HIV infection.

Németh G, Varga Z, Greff Z, Bencze G, Sipos A, Szántai-Kis C, Baska F, Gyuris A, Kelemenics K, Szathmáry Z, Minárovits J, Kéri G, Orfi L. Németh G, et al. Curr Med Chem. 2011;18(3):342-58. doi: 10.2174/092986711794839188. Curr Med Chem. 2011. PMID: 21143121

5

[Synthesis of 4-Chloro-6-(substituted-phenyl)-pyrimidines].

Németh G, Varga Z, Greff Z, Kéri G, Orfi L. Németh G, et al. Acta Pharm Hung. 2010;80(3):101-8. Acta Pharm Hung. 2010. PMID: 21222319 Hungarian.

6

[Developing FGFR inhibitors as potential anti-cancer agents].

Zsákai L, Németh G, Szántai-Kis C, Greff Z, Horváth Z, Szokol B, Baska F, Boon TC, Orfi L, Kéri G. Zsákai L, et al. Among authors: nemeth g. Acta Pharm Hung. 2013;83(2):47-56. Acta Pharm Hung. 2013. PMID: 23926649 Hungarian.

7

Synthesis and biological evaluation of novel pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines.

Kékesi L, Sipos A, Németh G, Pató J, Breza N, Baska F, Őrfi L, Kéri G. Kékesi L, et al. Among authors: nemeth g. Bioorg Med Chem Lett. 2013 Nov 15;23(22):6152-5. doi: 10.1016/j.bmcl.2013.09.005. Epub 2013 Sep 8. Bioorg Med Chem Lett. 2013. PMID: 24095095

8

[Development and study of structure-activity relationship of drugs against Mycobacterium tuberculosis].

Baska F, Székely ER, Szántai-Kis C, Bánhegyi P, Hegymegi-Barakonyi B, Németh G, Breza N, Zsákai L, Greff Z, Pató J, Kéri G, Orfi L. Baska F, et al. Among authors: nemeth g. Acta Pharm Hung. 2013;83(3):88-95. Acta Pharm Hung. 2013. PMID: 24369587 Hungarian.

9

Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors.

Németh G, Greff Z, Sipos A, Varga Z, Székely R, Sebestyén M, Jászay Z, Béni S, Nemes Z, Pirat JL, Volle JN, Virieux D, Gyuris Á, Kelemenics K, Ay E, Minarovits J, Szathmary S, Kéri G, Orfi L. Németh G, et al. J Med Chem. 2014 May 22;57(10):3939-65. doi: 10.1021/jm401742r. Epub 2014 May 2. J Med Chem. 2014. PMID: 24742150

10

[Pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines, and their preparation via regioselective condensation reaction].

Kékesi L, Sipos A, Németh G, Dancsó A, Illyés E, Boros S, Breza N, Nemes Z, Hegymegi-Barakonyi B, Pató J, Greff Z, Kéri G, Őrfi L. Kékesi L, et al. Among authors: nemeth g. Acta Pharm Hung. 2014;84(3):91-104. Acta Pharm Hung. 2014. PMID: 25470976 Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

563 results

Search Page